Get Restasis Online

Restasis contains cyclosporine, an anti-inflammatory agent that inhibits T-cell activation in the lacrimal gland. By reducing this inflammation, Restasis helps restore the gland's ability to produce a sufficient quantity of natural tears. It does not act as a lubricant itself; rather, it addresses the underlying inflammatory cause of reduced tear production.

Most patients do not experience full benefit immediately. Clinical studies show that significant improvement in tear production typically occurs after 3 to 6 months of consistent twice-daily use. Some patients notice gradual symptom improvement earlier, but it is important to continue using the drops as prescribed even if results are not immediate.

Restasis is used as one drop in each affected eye twice daily, approximately 12 hours apart. Each vial is single-use; discard it immediately after use even if solution remains. Remove contact lenses before instilling the drops and wait at least 15 minutes before reinserting them. Shake the vial gently before use to mix the emulsion.

Yes. Artificial tears can be used together with Restasis to provide additional lubrication and symptom relief, especially during the first few months of treatment. If you use both, administer them at least 15 minutes apart to avoid diluting the Restasis emulsion before it has time to work.

The most commonly reported side effect is a temporary burning sensation upon instillation, which occurs in a significant portion of users. Other possible effects include eye redness, discharge, watery eyes, blurred vision, and stinging. These reactions are usually mild and tend to lessen with continued use. Contact your physician if side effects are severe or persistent.

Restasis is contraindicated in patients with active ocular infections. It should be used with caution in individuals with a known hypersensitivity to cyclosporine or any component of the formulation. Patients with certain immune conditions should discuss their full medical history with their physician before starting therapy.

Doctronic uses an AI-powered evaluation to gather detailed information about your symptoms and medical history. A licensed physician then reviews your case, makes a clinical determination, and creates a personalized treatment plan. If a prescription is appropriate, it is sent directly to your pharmacy.

Yes. Doctronic connects you with real, U.S.-licensed physicians who review and are accountable for every treatment decision. All consultations are HIPAA-compliant and your medical information is kept private. The platform is designed to meet the same standards of care you would expect from an in-person visit.